In contrast, IR808-ATIPA, as a small-molecule iodine compound, activates the ferroptosis pathway in tumor cells, with its LPO regulated by GPX4 negative feedback, demonstrating a superior therapeutic window. This evidence concerns the gene GPX4 and neoplasm.